Stranica 1 iz 38 rezultatima
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to Korean Patent Application No. 10-2013-0073536, filed on Jun. 26, 2013, and all the benefits accruing therefrom under 35 U.S.C. .sctn.119, the contents of which in its entirety are herein incorporated by
BACKGROUND OF THE INVENTION
This invention relates generally to detection of cancerous cells and more particularly, to detecting cancerous cells using cellular autofluorescence.
The survival rate for cancer patients increases with early detection of cancer. Known methods of gaining early detection
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the diagnosis of cancer, and particularly to lung cancer detection by optical analysis of body fluids that uses fluorescence spectroscopy to examine samples of blood, urine, and/or sputum to diagnose cancer of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the diagnosis and discrimination of cancerous tumors, and particularly to a method for discriminating between benign and malignant prostate tumors that uses fluorescence spectroscopy to examine samples of blood,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the diagnosis of cancer, and particularly to the optical analysis of body fluids, such as blood or urine, by fluorescent spectroscopy in order to detect the presence of cancer and the relative severity or stage of
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
FIELD OF THE INVENTION
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present disclosure in general relates to the field of cancer development. More particularly, the present disclosure relates to a method or a kit for making risk evaluation of lung cancer in a subject.
2. Description of Related Art
DNA is
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2014/050330 filed 9 Jan. 2014, which claims priority to European Patent Application No. 13150974.7 filed 11 Jan. 2013. The entire contents of each
The present invention relates to an isolated peptide exhibiting antitumoral effects.
Every year millions of people are diagnosed with cancer worldwide. Notwithstanding in the last decades much progress has been achieved in cancer therapy, nevertheless cancer remains a leading cause of death.
BACKGROUND
1. Field of the Invention
The present invention relates generally to the field of peptides reactive with antibodies formed against human papillomavirus (HPV). Some have termed this type of peptide as antigenic or immunoreactive. More particularly, the invention relates to peptides
BACKGROUND
1. Field of the Invention
The present invention relates generally to the field of peptides reactive with antibodies formed against human papillomavirus (HPV). Some have termed this type of peptide as antigenic or immunoreactive. More particularly, the invention relates to peptides